-+ 0.00%
-+ 0.00%
-+ 0.00%

Cantor Fitzgerald Reiterates Overweight on MiMedx Group, Maintains $13 Price Target

Benzinga·02/27/2025 16:31:38
Listen to the news
Cantor Fitzgerald analyst Ross Osborn reiterates MiMedx Group (NASDAQ:MDXG) with a Overweight and maintains $13 price target.